Christchurch start-up Zuuka is initiating a capital raise to support the development of its prototype wearable drug-infusion pump as it prepares to enter the US market. The innovative technology, which is approximately half the size of existing patch pumps, was created by Dr. Jake Campbell at the University of Canterbury. Zuuka’s product aims to replace conventional motor-driven delivery systems with a more efficient, lower-power alternative that minimizes device size, charging needs, and operational complexity. This device will be compatible with a wide range of next-generation injectable medications for chronic and neurological conditions, alongside automated insulin delivery systems that can adapt to real-time glucose fluctuations. Campbell noted that practical and psychological barriers often hinder long-term treatment adherence more than medical issues.
Why It Matters
Wearable drug delivery systems are crucial for improving patient adherence to treatment plans, particularly for chronic diseases. The market for wearable medical devices is expected to grow significantly, driven by rising incidences of diabetes and other chronic health conditions. Zuuka’s innovative approach addresses common challenges associated with existing devices, such as size and user-friendliness, potentially leading to better health outcomes. This development aligns with a broader trend towards personalized and efficient healthcare solutions, reflecting advancements in medical technology and increasing patient demand for more manageable treatment options.
Want More Context? 🔎
